Cognitive impairment in heart failure is associated with altered Wnt signaling in the hippocampus

Camilo Toledo1,2, Claudia Lucero1, David C Andrade1,3

  • 1Laboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Santiago, Chile.

Aging
|August 27, 2019
PubMed

Insights

Heart failure (HF) in elderly patients often leads to cognitive impairment (CI). This study found HF rats showed memory loss and impaired learning, linked to Wnt/β-catenin pathway dysfunction in the brain.

Area of Science:

  • Neuroscience
  • Cardiovascular Science
  • Aging Research

Background:

  • Age is the primary risk factor for cardiovascular disease mortality.
  • Heart failure (HF) is prevalent in the elderly and frequently associated with cognitive impairment (CI).
  • While reduced brain oxygen supply is a known cause of CI in HF, mechanisms in HF without altered cerebral blood flow remain unclear.

Purpose of the Study:

  • To investigate learning and memory functions in a rodent model of HF without changes in cerebral blood flow.
  • To explore the underlying pathophysiological mechanisms of CI in this specific HF subset.

Main Methods:

  • Utilized a rodent model of heart failure (HF) exhibiting normal brain perfusion.
  • Assessed learning and memory performance in HF rats.
  • Analyzed Wnt/β-catenin signaling pathway elements in the hippocampus of HF rats.

Main Results:

  • HF rats demonstrated significant learning impairments and memory deficits.
  • HF rats exhibited reduced levels of Wnt/β-catenin signaling downstream components in the hippocampus.
  • These findings suggest a link between HF, CI, and Wnt/β-catenin pathway alterations.

Conclusions:

  • Cognitive impairment in HF rats, even without altered cerebral blood flow, is associated with Wnt/β-catenin signaling pathway dysfunction.
  • Further research is needed to elucidate the precise mechanisms linking Wnt/β-catenin signaling alterations to CI development in HF.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
768
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
720
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
273